The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Myriad Genetics, Inc(NASDAQ:MYGN) 
Myriad Genetics, Inc., a molecular diagnostic company, develops and markets predictive, personalized, and prognostic medicine tests in the United States and internationally. The company offers myRisk Hereditary Cancer, a DNA sequencing test for hereditary cancers; BRACAnalysis, a DNA sequencing test...
Website: http://www.myriad.com
Founded: 1991
Full Time Employees: 2,700
Sector: Healthcare
Industry: Diagnostics & Research
Myriad Genetics Days Payable Outstanding ttm (DPO)
Myriad Genetics Days Receivable Outstanding ttm (DSO)
Myriad Genetics Days Inventory Outstanding ttm (DIO)
Myriad Genetics Op Cashflow Per Share ttm
Myriad Genetics Free Cashflow Per Share ttm
Myriad Genetics Cash Per Share ttm
Myriad Genetics P/S ratio ttm
Myriad Genetics (GAAP) P/E ratio ttm
Myriad Genetics P/B ratio ttm
No extra charts and metrics for this ticker.